Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

December 2013 - FRMC

Department

News Connection
Vedolizumab for Crohn’s Disease
12/17/2013
Results of a trial show that patients with active Crohn’s disease treated with induction vedolizumab were more likely to have clinical remission.
Results of a trial show that patients with active Crohn’s disease treated with induction vedolizumab were more likely to have clinical remission.
Results of a trial show that...
12/17/2013
First Report Managed Care
News Connection
Mortality, Outcomes, and Healthcare Utilization with Spinal Augmentation
12/17/2013
Vertebroplasty and kyphoplasty, known collectively as spinal augmentation, have received widespread acceptance as effective, minimally invasive treatments for rapid symptomatic relief following osteoporotic vertebral compression fractures....
Vertebroplasty and kyphoplasty, known collectively as spinal augmentation, have received widespread acceptance as effective, minimally invasive treatments for rapid symptomatic relief following osteoporotic vertebral compression fractures....
Vertebroplasty and kyphoplasty,...
12/17/2013
First Report Managed Care
News Connection
Screening Reduces Colon Cancer Death
12/17/2013
In a 30-year follow-up of participants in the Minnesota Colon Cancer Control Study, researchers found that annual screening with fecal occult-blood testing reduced the risk of death from colon cancer by 32%. 
In a 30-year follow-up of participants in the Minnesota Colon Cancer Control Study, researchers found that annual screening with fecal occult-blood testing reduced the risk of death from colon cancer by 32%. 
In a 30-year follow-up of...
12/17/2013
First Report Managed Care
News Connection
Surgery for Initial Treatment of Moderate-to-Severe Stress UI
12/17/2013
Results of multicenter, randomized trial show that women with moderate-to-severe stress urinary incontinence (UI) treated by surgery have higher rates of subjective and objective outcomes at 1 year compared with women treated by initial...
Results of multicenter, randomized trial show that women with moderate-to-severe stress urinary incontinence (UI) treated by surgery have higher rates of subjective and objective outcomes at 1 year compared with women treated by initial...
Results of multicenter,...
12/17/2013
First Report Managed Care
News Connection
Cardioprotective Benefit of DPP-4 Inhibitor Unclear
12/17/2013
Although the selective dipeptidyl peptidase 4 (DPP-4) inhibitor saxagliptin significantly improved glycemic control in patients with type 2 diabetes, the risk of hospitalization for heart failure increased, as did the risk of hypoglycemic...
Although the selective dipeptidyl peptidase 4 (DPP-4) inhibitor saxagliptin significantly improved glycemic control in patients with type 2 diabetes, the risk of hospitalization for heart failure increased, as did the risk of hypoglycemic...
Although the selective...
12/17/2013
First Report Managed Care
News Connection
Kidney Transplant Outcomes in Adolescents
12/17/2013
The most common end-stage organ disease in children and adolescents is renal failure. The 10-year survival for adolescent-onset end-stage renal disease is 80%. It has been shown in previous studies that compared with younger recipients,...
The most common end-stage organ disease in children and adolescents is renal failure. The 10-year survival for adolescent-onset end-stage renal disease is 80%. It has been shown in previous studies that compared with younger recipients,...
The most common end-stage organ...
12/17/2013
First Report Managed Care
Alogliptin and Cardiovascular Events in Patients with Diabetes
12/17/2013
A noninferiority study of a new drug for type 2 diabetes found that patients with a very high cardiovascular risk did not have any increased major cardiovascular events while taking alogliptin, but did have better glycemic control, compared...
A noninferiority study of a new drug for type 2 diabetes found that patients with a very high cardiovascular risk did not have any increased major cardiovascular events while taking alogliptin, but did have better glycemic control, compared...
A noninferiority study of a new...
12/17/2013
First Report Managed Care
Fixed-Dose Combination in Patients with or at High Risk of CVD
12/17/2013
Results of a randomized, open-label, blinded-end-point trial show significantly improved medication adherence at 15 months and significant, albeit small, improvements in systolic blood pressure (SBP) and low-density lipoprotein cholesterol...
Results of a randomized, open-label, blinded-end-point trial show significantly improved medication adherence at 15 months and significant, albeit small, improvements in systolic blood pressure (SBP) and low-density lipoprotein cholesterol...
Results of a randomized,...
12/17/2013
First Report Managed Care
Study Finds Link between Calcium-Channel Blockers and Breast Cancer
12/17/2013
The first observational study of long-term antihypertensive use and breast cancer risk found that calcium-channel blockers are associated with a greater than 2-fold increase in the risk of breast cancer in postmenopausal women.
The first observational study of long-term antihypertensive use and breast cancer risk found that calcium-channel blockers are associated with a greater than 2-fold increase in the risk of breast cancer in postmenopausal women.
The first observational study of...
12/17/2013
First Report Managed Care

News

Newsfeed
Less Than One-Third of TTEs Lead to Change in Patient Care
12/17/2013
Although almost all transthoracic echocardiograms (TTEs) were deemed appropriate, only 1 in 3 resulted in an active change in the patient’s care and about 1 in 5 resulted in no change in care, according to results of a recent study [JAMA...
Although almost all transthoracic echocardiograms (TTEs) were deemed appropriate, only 1 in 3 resulted in an active change in the patient’s care and about 1 in 5 resulted in no change in care, according to results of a recent study [JAMA...
Although almost all...
12/17/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

The Pharmaceutical Pipeline: 2011 and Beyond
11/29/2011
Atlanta—The number of drugs granted US Food and Drug Administration (FDA) approval decreased markedly in 2011 compared with other years. The FDA approval rate has slowed and the number of drugs under development has decreased, leading to a...
Atlanta—The number of drugs granted US Food and Drug Administration (FDA) approval decreased markedly in 2011 compared with other years. The FDA approval rate has slowed and the number of drugs under development has decreased, leading to a...
Atlanta—The number of drugs...
11/29/2011
First Report Managed Care
News
Buying Brand-Name Drugs Over Generics Raises Medicaid Costs
03/30/2011
03/30/2011
First Report Managed Care
News
Consumer-directed health plans show mixed results
05/08/2012
05/08/2012
First Report Managed Care
News
Low Rate of Endometrial Abnormalities in Women Taking Tamoxifen
06/09/2016
Findings from a new study may ease the minds of women taking tamoxifen for breast cancer, according to researchers at Loyola Medicine.
Findings from a new study may ease the minds of women taking tamoxifen for breast cancer, according to researchers at Loyola Medicine.
Findings from a new study may...
06/09/2016
First Report Managed Care
Headshots of Edmund Pezalla, Adam Kittai, Farrukh Awan, Jeffrey Dunn
Podcasts
Future of Care in CLL: Provider, Managed Care Perspectives
12/21/2022
Adam Kittai, MD, hematology specialist and assistant professor of medicine, Ohio State University; Farrukh Awan, MD, professor of internal medicine, UT Southwestern Medical Center; and Jeffrey Dunn, PharmD, MBA, chief clinical officer,...
Adam Kittai, MD, hematology specialist and assistant professor of medicine, Ohio State University; Farrukh Awan, MD, professor of internal medicine, UT Southwestern Medical Center; and Jeffrey Dunn, PharmD, MBA, chief clinical officer,...
Adam Kittai, MD, hematology...
12/21/2022
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

December 2013 Volume 10 Issue 12

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement